Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04670458
Other study ID # IHCA-EWS-QLH
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 1, 2020
Est. completion date December 31, 2021

Study information

Verified date December 2020
Source Qilu Hospital of Shandong University
Contact Wentao Sang
Phone 15153187102
Email 752318151@qq.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Current studies have shown that hospitalized ICU patients have a high risk of IHCA, with an incidence of about 0.6-7.8%. Early prediction of the occurrence of IHCA in severe patients can provide early intervention, prevent the deterioration of the disease, and reduce the incidence of IHCA. Therefore, researchers wanted to verify the efficacy of MEWS, NEWS, and CART scores in predicting IHCA in ICU inpatients, and to establish an early-warning scoring model that could effectively predict the risk of IHCA occurrence in ICU inpatients during hospitalization.


Recruitment information / eligibility

Status Recruiting
Enrollment 2000
Est. completion date December 31, 2021
Est. primary completion date September 30, 2021
Accepts healthy volunteers No
Gender All
Age group 14 Years and older
Eligibility CA group Inclusion Criteria: - Occurrence of IHCA - Hospital stay =48h. Exclusion Criteria: - <14 years - Do Not Resuscitat - Patients hospitalized due to out-of-hospital cardiac arrest - Cardiac arrest occurs during the operation - The patients with implanted cardiac pacemaker suffered cardiac arrest due to instrument malfunction. CONTROL group Inclusion Criteria: - Without IHCA - Hospital stay =48h Exclusion Criteria: - <14 years - Leave hospital without medical advice

Study Design


Related Conditions & MeSH terms


Intervention

Other:
no intervention
no intervention

Locations

Country Name City State
China Qilu Hospital of Shandong University Jinan Shandong

Sponsors (1)

Lead Sponsor Collaborator
Qilu Hospital of Shandong University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary In-Hospital Cardiac Arrest Cardiac arrest occurs during hospitalization Day 2
See also
  Status Clinical Trial Phase
Recruiting NCT03220269 - RIAC - Registro Italiano Arresti Cardiaci (Italian Registry of Cardiac Arrest) N/A
Completed NCT04786860 - The Success Rate of Cardiopulmonary Resuscitation in Patients Experiencing In-hospital Cardiac Arrest
Completed NCT04480515 - Does COVID-19 Pandemic Reduce In-hospital Mortality?
Completed NCT05184972 - Coverage and Validity of the Swedish Registry of Cardiopulmonary Resuscitation Regarding In-hospital Cardiac Arrest
Active, not recruiting NCT02858778 - Timing of Acute Palliative Care Consultation in Critically Ill Patients N/A
Completed NCT02368392 - National Cardiac Arrest Survey N/A
Withdrawn NCT03384810 - Inhospital Resuscitation: Incidence, Causes and Outcome
Withdrawn NCT04220619 - RescueTEE for In-hospital Cardiac Arrest (ReTEECA Trial) N/A
Completed NCT03378518 - Evaluation of Effectiveness of Blue Code Team After In-hospital Cardiopulmonary Arrest N/A
Recruiting NCT04675918 - Pediatric In-Hospital Cardiac Arrest International Registry (PACHIN)
Completed NCT03498508 - Poor Theoretical Knowledge and Self-assessed Ability of Cardiopulmonary Resuscitation Among In-hospital Healthcare Professionals: a Cross Sectional Study With Questionnaires.
Completed NCT04321213 - In-hospital Healthcare Professionals' Attitudes and Their Experience in Performing Cardiopulmonary Resuscitation.
Completed NCT02122549 - Hospital Wearable Defibrillator Inpatient Study N/A